Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
ReumatologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- BMJ (Clinical research ed.)
- Publicado em
- 27 jun 2025
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
Ying Zhou, Rusha Yin, Yuelun Zhang, Xuemei Wang, Fengbin Jin, Xiangjuan Li, Cheng Peng, Ping Wang, Haiyan Shen, Qiao Weng et al.
Descritores MeSH
- Estrogens, Conjugated (USP)
- Pessaries
- Estrogens
- Pelvic Organ Prolapse
- Female
- Administration, Intravaginal
- Middle Aged
- Vaginal Creams, Foams, and Jellies
- Treatment Outcome
- Patient Satisfaction
Veja também
Estudos relacionados
- From tissue to outcome - how perioperative vaginal estrogen transforms prolapse surgery results: a systematic review and meta-analysis of clinical evidence and outcomes
- Three-year outcomes of a randomized clinical trial of perioperative vaginal estrogen as adjunct to native tissue vaginal apical prolapse repair
- Comparison of estradiol hemihydrate 10 µg vaginal tablets versus estradiol hemihydrate 10 µg vaginal gel in postmenopausal women with vaginal atrophy: a randomized crossover study
- Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study
- Factors for Vaginal Epithelium-Related Adverse Events in Pessary Users: A Secondary Analysis of a Randomized Controlled Trial